Immune design corp. (IMDZ)
Income statement / TTM
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Sep'13Jun'13
Revenues:
Total revenues

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaborative revenue

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Licensing revenue

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

0

0

-

0

0

Collaborative revenue

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

0

0

0

-

0

Product sales

-

-

-

61

-

-

-

1,881

-

2,087

2,485

1,771

1,853

1,680

900

945

881

249

573

0

0

0

Total revenues

-

-

-

2,233

-

-

-

16,862

-

12,341

8,788

9,435

9,510

10,171

9,062

8,346

6,433

4,762

2,100

0

0

0

Operating expenses:
Cost of product sales

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cost of product sales

-

-

176

54

-

-

261

496

-

700

926

717

774

996

729

703

638

133

352

0

0

0

Research and development

42,415

41,102

40,080

39,943

43,670

47,152

48,079

48,602

45,134

42,007

39,097

36,194

33,087

33,006

30,731

26,131

22,746

16,869

14,237

0

0

0

General and administrative

15,396

16,124

16,231

16,113

16,253

16,375

22,020

22,080

21,859

21,464

15,416

15,246

15,134

16,635

17,211

15,283

12,927

8,510

5,342

0

0

0

Total operating expenses

59,246

57,418

56,487

56,110

60,007

63,732

70,360

71,178

67,474

64,171

55,439

52,157

48,995

50,637

48,671

42,117

36,311

25,512

19,931

0

0

0

Loss from operations

-57,050

-55,213

-54,228

-53,877

-52,812

-54,964

-53,902

-54,316

-54,214

-51,830

-46,651

-42,722

-39,485

-40,466

-39,609

-33,771

-29,878

-20,750

-17,831

0

0

0

Interest and other income

2,292

2,076

1,724

1,335

950

636

547

460

684

631

488

389

40

16

11

3

4

2

4

0

0

0

Change in fair value of convertible preferred stock warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,277

4,277

4,150

0

0

0

Net loss

-54,758

-53,137

-52,504

-52,542

-51,862

-54,328

-53,355

-53,856

-53,530

-51,199

-46,163

-42,333

-39,445

-40,450

-39,725

-35,334

-34,151

-25,025

-21,977

0

0

0

Unrealized gain (loss) on investments

47

-5

8

-20

-25

-21

-73

-67

-24

7

30

20

0

0

0

0

-

-

-

-

-

-

Comprehensive loss

-54,711

-53,142

-52,496

-52,562

-51,887

-54,349

-53,428

-53,923

-53,554

-51,192

-46,133

-42,313

-39,445

0

0

0

-

-

-

-

-

-

Basic and diluted net loss per share (in dollars per share)

-0.28

-0.29

-0.29

-0.28

-0.19

-0.52

-0.54

-0.50

-0.55

-0.60

-0.71

-0.61

-0.59

-0.37

-0.54

-0.56

34.81

-0.55

-16.57

-22.25

-10.81

-9.84

Weighted-average shares used to compute basic and diluted net loss per share (in shares)

48,168

48,164

48,125

48,122

41,856

25,620

25,567

25,463

25,441

20,803

20,155

20,153

20,191

20,131

19,356

16,944

17,110

12,128

369

369

369

369